Significance of Proto-Oncogene Bcl-X_S/L Expression in Wilms Tumor

References

• Monaghan, P.; Robertson, D.; Aamos, T.; Dyer, M J.; Mason, D J.; Graves, M F. Ultrastructural localization of bcl-2 protein. J. Histochem. Cytochem. 1992, 40, 1819. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ghanem, M A.; Van der Kwast, T H.; Den Hollander, J C.; Sudaryo, M K.; Van den Heuvel, M M.; Noordzij, M A.; Nijman, R J.M.; Soliman, E H.; van Steenbrugge, G J. The prognostic significance of apoptosis-associated proteins bcl-2, bax and bcl-x in clinical nephroblastoma. Br. J. Cancer 2001, 85 (10), 1557–1563. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Strasser, A.; Huang, S C.D.; Vaux, L D. The role of the bcl-2/ced-9 gene family in cancer and general implication of defects in cell death control for tumorigenesis and resistance to chemotherapy. Biochim. Biophys. Acta 1997, 151–178.
   Google Scholar
• Charles, K A.; Vujanic, M G.; Berry, J P. Renal tumours of childhood. Histopathology 1998, 32, 293–309. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Conner, A E.; Teramoto, T.; Wirth, J P.; Garfield, S.; Thorgeirsson, S S. HGF-mediated apoptosis via p53/bax-independent pathway activating JNK1. Carcinogenesis 1999, 20 (4), 583–590. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Vujanic, M G.; Sandstedt, B.; Harms, D.; Leuschner, I.; de Kraker, J. Revised International Society of Pediatric Oncology (SIOP) working classification of renal tumors of childhood. Med. Pediatr. Oncol. 2002, 38, 79–82. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Gobe, G.; Zhang, X.; Willgoss, A D.; Schoch, E.; Hogg, N A.; Endre, Z. Relationship between expression bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J. Am. Soc. Nephrol. 2000, 11 (3), 454–467. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Clapp, W L.; Cloker, B P. Adult kidney. In Hystology for Pathologists; Stenberger, S S., Ed.; Lippincett Raven: Philadelphia, 1997; 799–834.
   Google Scholar
• Gobe, G.; Rubin, M.; Williams, G.; Sawczuk, I.; Buttyan, R. Apoptosis and expression of bcl-2, bcl-XL, and Bax in renal cell carcinomas. Cancer Investig. 2002, 20 (3), 324–332. [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sakuragi, N.; Salah-eldin, A E.; Watari, H.; Itoh, T.; Inoue, S.; Moriuchi, T.; Fujimoto, S. Bax, Bcl-2 and p53 expression in endometrial cancer. Gynecol. Oncol. 2002, 86 (3), 288–296. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gazzaniga, P.; Gradilone, A.; Vercillo, R.; Gandini, O.; Silvestri, I.; Napolitano, M.; Albonici, L.; Vincenzoni, A.; Gallucci, M.; Frati, L.; Agliano, A M. Bcl-2/Bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancer. Int. J. Cancer 1996, 69 (2), 100–104. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jansson, A.; Sun, X F. Bax expression decreases significantly from primary tumor to metastasis in colorectal cancer. J. Clin. Oncol. 2002, 20 (3), 811–816. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Vasavada, S P.; Novick, A C.; Williams, B R. P53, bcl-2 and bax expression in renal cell carcinoma. Urology 1998, 51 (6), 1057–1061. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Gallo, G.; Giarnieri, E.; Bosco, S.; Cappelli, C.; Alderisio, M.; Giovagnoli, M R.; Giordano, A.; Vecchione, A. Abberant bcl-2 and bax protein expression related to chemotherapy response in neuroblastoma. Anticancer Res. 2003, 23 (1B), 777–784. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Re, G G.; Hazen-Martin, D J.; El Bahtimi, R.; Brownlee, N A.; Willingham, M C.; Garvin, A J. Prognostic significance of Bcl-2 in Wilms tumor and oncogenic potential of Bcl-X(L) in rare tumor cases. Int. J. Cancer 1999, 84 (2), 192–200., [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Tanaka, K.; Granata, C.; Wang, Y.; O'Briain, D S.; Puri, P. Apoptosis and bc-2 oncogene expression in Wilm's tumor. Pediatr. Surg. Int. 1999, 15 (3–4), 243–247. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Wunsch, L.; Flemming, P.; Gluer, S. Expression of MIB and Bcl-2 in patients with nephrogenic rests with and without associated Wilms tumors. Eur. J. Pediatr. Surg. 2001, 11 (2), 105–109. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Krajewski, S.; Blomqvist, C.; Franssila, K.; Krajewska, M.; Wasenius, V M.; Niskanen, E.; Nordling, S.; Reed, J C. Reduced expression of proapoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 1995, 55 (19), 4471–4478. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Pammer, J.; Exner, M.; Regele, H.; Haitel, A.; Weninger, W.; Horvat, R.; Susani, M. Expression of bcl-2, bcl-x, bax and bak in renal parenchyma, oncocytomas and renal cell carcinomas. Path. Res. Pract. 1998, 194 (12), 837–845. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Mackey, T J.; Borkowski, A.; Amin, P.; Jacobs, S C.; Kyprianou, N. bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer. Urology 1998, 52 (6), 1085–1090. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Nasierowska-Guttmejer, A. The comparison of immunohistochemical proliferation and apoptosis markers in rectal carcinoma treated surgically or by preoperative radio-chemotherapy. Pol. J. Pathol. 2001, 52 (1–2), 53–61. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Sjostrom, J.; Blomqvist, C.; von Boguslawski, K.; Bengtsson, N O.; Mjaaland, I.; Malmstrom, P.; Ostenstadt, B.; Wist, E.; Valvere, V.; Takayama, S.; Reed, J C.; Saksela, E. The predictive value of bcl-2, bax, bcl-xL, bag-1, fas and fas-l for chemotherapy response in advanced breast cancer. Clin. Cancer Res. 2002, 8 (3), 811–816. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar